Document and Entity Information
Mar. 10, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 10, 2022
Entity Registrant Name Gemini Therapeutics, Inc. /DE
Entity Incorporation, State or Country Code DE
Entity File Number 001-39438
Entity Tax Identification Number 85-1612845
City Area Code 617
Local Phone Number 401-4400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol GMTX
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Address, Postal Zip Code 00000
Entity Central Index Key 0001816736
Amendment Flag false